Galderma R&d
Clinical trials sponsored by Galderma R&d, explained in plain language.
-
Filler study aims to plump sunken temples
Symptom relief OngoingThis study tests whether Restylane Volyme, a dermal filler, can safely improve the appearance of sunken temples. 162 adults with moderate to severe temple hollowing received either the filler or no treatment. The main goal is to see if the filler provides a noticeable improvement…
Phase: NA • Sponsor: Galderma R&D • Aim: Symptom relief
Last updated Jun 18, 2026 11:46 UTC
-
New drug shows promise for chronic itch in Long-Term trial
Symptom relief OngoingThis study looks at the long-term safety of nemolizumab in 500 adults with prurigo nodularis, a condition causing severe itching and skin bumps. Participants must have taken nemolizumab in a previous study. The main goal is to track side effects over time, while also checking if …
Phase: PHASE3 • Sponsor: Galderma R&D • Aim: Symptom relief
Last updated Jun 15, 2026 18:54 UTC